Lowest Price Guaranteed From USD 4,799
The surgical robots market has experienced significant growth and technological advancements since its inception in the 1970s. Surgical robots, also known as robot-assisted surgery, are a promising technology in the field of medicine that allows doctors to perform complex procedures with more precision, flexibility, and control than conventional techniques. These robots are typically used in minimally invasive surgery, which involves small incisions and often includes the use of a camera arm and mechanical arms with surgical instruments attached to them. The surgeon controls the robotic arms from a nearby computer console near the operating table, providing a high definition, magnified, 3D view of the surgical site.
According to Intuitive Surgical, Inc., a market leader in the surgical robots market, over 13 million procedures have been performed using Da Vinci system, Robotically Assisted Surgical Systems (RASS) from the company to date. Of these, more than 1.8 million procedures were performed in 2022 alone. The market has seen a surge in demand for surgical robots, driven by factors such as the increasing need for knee and hip replacement surgeries, demand for minimally invasive surgery procedures, technological advancements, and the growing focus of governments and private players to reduce healthcare expenditure.
The surgical robots market analysis includes leading companies, their product portfolio, surgical robots under development, market share, partnerships, collaborations, funding, market size and opportunity, recent market trends and developments over the forecast period. This market is the fastest growing segment of the overall medical robotics market.
The market growth drivers in the surgical robots market include technological advancements, the advantages of robotic-assisted surgery, increasing adoption of surgical robots, and increased funding for medical robot research. Technological advancements have allowed the use of surgical robots for conducting minimally invasive procedures. Additionally, through the availability of 5G connectivity, surgical robots are also being deployed for telesurgery, a branch of telemedicine market. Some Asia Pacific countries including, Indonesia and Singapore demonstrated success with telesurgery. The Indonesian government began a telesurgery project in 2021, and used surgical robots from Sina Robotics for its pilot project.
Additionally, a number of RASS have been installed across various hospitals. 1,200 Da Vinci system from Intuitive Surgical were installed in 2022. Another UK based company, CMR Surgical announced that it ended 2023 with a 50% increase in its total installed base for its Versius surgical robot compared to the previous year. These factors will continue to drive the expansion of the global surgical robots market over the forecast period.
Market restraints in the surgical robots market include the high cost of robotic systems, which can hinder their adoption attributing to the significant upfront investment required and the need for high surgical volume to ensure cost-effectiveness. The most popular surgical robot, Da Vinci system, is priced around $1.5 million. A number of local companies have recently launched their robotic systems at lower prices, to cater to the domestic markets. India based SS Innovations launched SS Mantra at the end of 2022 at a price tag of INR 5 crore. In addition to the upfront cost, the use of a robot for a surgical procedure adds significant cost to the total procedure due to the requirement to purchase replacement parts per procedure. As per Intuitive Surgical, $600 - $3,500 worth of instruments and accessories are sold per procedure using Da Vinci system. As such their use has been limited to specific cases.
Additionally, the lack of a clear liability framework for the risks arising from the interplay between surgeons and robots, as well as the progressive autonomy levels of surgical robots, presents challenges in terms of regulation and liability allocation. These factors contribute to the restraints in the market for surgical robots, despite the potential benefits they offer in terms of improved patient outcomes and increased cost-effectiveness.
Intuitive Medical has dominated the market for several years; however, a number of domestic companies have now successfully developed and launched their systems in the local markets at competitive prices. There is immense opportunities available for the companies at this stage to fill the gaps in this niche market.
Factors such as the growing prevalence of cancers, degenerative bone disorders, and rising government initiatives are expected to influence the market. Additionally, the market is witnessing a surge owing to the rising geriatric population, increasing incidences of chronic diseases, growing inclination towards minimally invasive surgical approaches, and technological advancements in product manufacturing.
The Surgical robots market forecast on the basis of products (laparoscopy robotic systems, orthopedic robotic systems, neurosurgical robotic systems and other systems). On the basis of application (general surgery, gynecological surgery, orthopedic surgery, urological surgery, neurosurgery and other applications). On the basis of end user (hospitals and clinics, ambulatory surgery centers and other end users). By geographical regions, the market is analyzed across North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.
Based on applications, the surgical robots market is analyzed across general surgery, gynecological surgery, orthopedic surgery, urological surgery, neurosurgery and other applications. The segment of oncology, laparoscopy, and other general surgical procedures are expected to capture the largest revenue share in this domain. The growing usage of robots for cancer treatment procedures and the increasing demand for minimally invasive laparoscopic surgeries are key factors contributing to the segment's high share. The neurology segment is anticipated to register the fastest CAGR, as the adoption of robots in neurosurgeries, offering benefits over traditional surgery techniques, will boost the segment's growth.
Based on region, the surgical robots market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to hold the largest share in the robotic-assisted surgery market, primarily due to improvements in surgeries and healthcare facilities for various disorders. Factors contributing to market growth include higher favorable outcomes compared to open surgeries, shorter periods of hospitalization and recovery for children, and improvements in the miniaturization of instruments. Asia Pacific is anticipated to witness high CAGR over the coming years, mainly led by growth in India, China, Singapore, Indonesia, and Australia. Increasing government initiatives to encourage healthcare providers and other healthcare organizations to adopt technologically advanced medical devices and systems are also driving market growth. These factors contribute to the growth of the robotic-assisted surgery market, which is expected to experience significant growth in the coming years.
Key market players that are engaged in surgical robots market are (in alphabetical order) ACCURAY, Corindus Vascular Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Omnicell, Renishaw, Stryker Corporation, TransEnterix and Zimmer Biomet. This market report includes an easily searchable excel database of all the surgical robots companies worldwide.
Key Geographical Regions
Key Market Players
Recent Developments in Surgical Robots Market
There has been recent activity in the surgical robots industry and some of the key developments have been mentioned below: